Close Menu

BioSource International and Whatman Schleicher & Schuell are set to launch the first commercially available planar phosphoarray, the companies said this week.

The array, called the Mercatur Phosophoarray, contains 10 analytes — each specific for a different phosphosite. The decision to make the new array grew out of customers’ demand for a product that could analyze multiple phosphosites at the same time, said Chris Brotski, senior product manager for Camarillo, Calif.-based BioSource International.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.